Treasury Ltd Artal serves as Executive at LEXICON PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Treasury Ltd Artal has executed 3 insider transactions totaling $42.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2020 involved purchasing 10,937,500 shares valued at $35.0M.
Treasury Ltd Artal currently holds 32,259,461 shares of LEXICON PHARMACEUTICALS, INC. (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Treasury Ltd Artal has been a net buyer of LXRX stock. They have purchased $42.4M and sold $0 worth of shares.
Treasury Ltd Artal's most recent insider trade was on Dec 16, 2020, when they purchased 10,937,500 shares at $3.20 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 3, 2020 | SQZ | $7.4M | Purchase | 465,000 | $16.00 | Discretionary |